Candesartan vs Durvalumab

## Candesartan vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Durvalumab**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Durvalumab — N/A.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Durvalumab — N/A.

**Type**: Candesartan — Small molecule; Durvalumab — Antibody.